Molecular and Vascular MRI of Placenta Accreta

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3R01HD094347-03S1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $156,621
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    Ananth V Annapragada
  • Research Location

    United States of America
  • Lead Research Institution

    Baylor College Of Medicine
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

An understanding of the transplacental transport of the SARS-CoV-2 virion is of enormous importance.Objective characterization of virion transport, even in animal models, is a hugely challenging task. Usingtransplacental transport as an example, we seek to address this problem: we will design and build a VirionSurrogate Particle (VSP). Binding of the VSP to target receptors (ACE2), and subsequent internalization willbe validated in cell culture, followed by in vivo testing of transplacental transport. The specific aims for thissupplement are thereore: 1. Prepare Virus Surrogate Particles (VSP), recapitulating the viral lipid envelope, bearing the Spike protein S on the surface and carrying proteolytic Furin in the lumen, and validate binding of VSP to the ACE2 receptor in cell culture studies. 2. Study trans-placental transport of VSP in the k18-hACE2 mouse model with the humanized ACE2 receptor throughout the course of pregnancy using MR, CT and fluorescence tracing of particles 3. Study the effect of known ACE2 receptor level effectors (low protein diet, hypertension, high fat diet) on transplacental transport of VSP